Cargando…

Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects

A series of hybrid of triazoloquinoxaline-chalcone derivatives 7a–k were designed, synthesized, fully characterized, and evaluated for their cytotoxic activity against three target cell lines: human breast adenocarcinoma (MCF-7), human colon carcinoma (HCT-116), and human hepatocellular carcinoma (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Alswah, Mohamed, Bayoumi, Ashraf H., Elgamal, Kamal, Elmorsy, Ahmed, Ihmaid, Saleh, Ahmed, Hany E. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943945/
https://www.ncbi.nlm.nih.gov/pubmed/29280968
http://dx.doi.org/10.3390/molecules23010048
_version_ 1783321727124635648
author Alswah, Mohamed
Bayoumi, Ashraf H.
Elgamal, Kamal
Elmorsy, Ahmed
Ihmaid, Saleh
Ahmed, Hany E. A.
author_facet Alswah, Mohamed
Bayoumi, Ashraf H.
Elgamal, Kamal
Elmorsy, Ahmed
Ihmaid, Saleh
Ahmed, Hany E. A.
author_sort Alswah, Mohamed
collection PubMed
description A series of hybrid of triazoloquinoxaline-chalcone derivatives 7a–k were designed, synthesized, fully characterized, and evaluated for their cytotoxic activity against three target cell lines: human breast adenocarcinoma (MCF-7), human colon carcinoma (HCT-116), and human hepatocellular carcinoma (HEPG-2). The preliminary results showed that some of these chalcones like 7b–c, and 7e–g exhibited significant antiproliferative effects against most of the cell lines, with selective or non-selective behavior, indicated by IC(50) values in the 1.65 to 34.28 µM range. In order to investigate the mechanistic aspects of these active compounds, EGFR TK and tubulin inhibitory activities were measured as further biological assays. The EGFR TK assay results revealed that the derivatives 7a–c, 7e, and 7g could inhibit the EGFR TK in the submicromolar range (0.093 to 0.661 µM). Moreover, an antitubulin polymerization effect was noted for the active derivatives compared to the reference drug colchicine, with compounds 7e and 7g displaying 14.7 and 8.4 micromolar activity, respectively. Furthermore, a molecular docking study was carried out to explain the observed effects and the binding modes of these chalcones with the EGFR TK and tubulin targets.
format Online
Article
Text
id pubmed-5943945
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-59439452018-11-13 Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects Alswah, Mohamed Bayoumi, Ashraf H. Elgamal, Kamal Elmorsy, Ahmed Ihmaid, Saleh Ahmed, Hany E. A. Molecules Article A series of hybrid of triazoloquinoxaline-chalcone derivatives 7a–k were designed, synthesized, fully characterized, and evaluated for their cytotoxic activity against three target cell lines: human breast adenocarcinoma (MCF-7), human colon carcinoma (HCT-116), and human hepatocellular carcinoma (HEPG-2). The preliminary results showed that some of these chalcones like 7b–c, and 7e–g exhibited significant antiproliferative effects against most of the cell lines, with selective or non-selective behavior, indicated by IC(50) values in the 1.65 to 34.28 µM range. In order to investigate the mechanistic aspects of these active compounds, EGFR TK and tubulin inhibitory activities were measured as further biological assays. The EGFR TK assay results revealed that the derivatives 7a–c, 7e, and 7g could inhibit the EGFR TK in the submicromolar range (0.093 to 0.661 µM). Moreover, an antitubulin polymerization effect was noted for the active derivatives compared to the reference drug colchicine, with compounds 7e and 7g displaying 14.7 and 8.4 micromolar activity, respectively. Furthermore, a molecular docking study was carried out to explain the observed effects and the binding modes of these chalcones with the EGFR TK and tubulin targets. MDPI 2017-12-25 /pmc/articles/PMC5943945/ /pubmed/29280968 http://dx.doi.org/10.3390/molecules23010048 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alswah, Mohamed
Bayoumi, Ashraf H.
Elgamal, Kamal
Elmorsy, Ahmed
Ihmaid, Saleh
Ahmed, Hany E. A.
Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
title Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
title_full Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
title_fullStr Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
title_full_unstemmed Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
title_short Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
title_sort design, synthesis and cytotoxic evaluation of novel chalcone derivatives bearing triazolo[4,3-a]-quinoxaline moieties as potent anticancer agents with dual egfr kinase and tubulin polymerization inhibitory effects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943945/
https://www.ncbi.nlm.nih.gov/pubmed/29280968
http://dx.doi.org/10.3390/molecules23010048
work_keys_str_mv AT alswahmohamed designsynthesisandcytotoxicevaluationofnovelchalconederivativesbearingtriazolo43aquinoxalinemoietiesaspotentanticanceragentswithdualegfrkinaseandtubulinpolymerizationinhibitoryeffects
AT bayoumiashrafh designsynthesisandcytotoxicevaluationofnovelchalconederivativesbearingtriazolo43aquinoxalinemoietiesaspotentanticanceragentswithdualegfrkinaseandtubulinpolymerizationinhibitoryeffects
AT elgamalkamal designsynthesisandcytotoxicevaluationofnovelchalconederivativesbearingtriazolo43aquinoxalinemoietiesaspotentanticanceragentswithdualegfrkinaseandtubulinpolymerizationinhibitoryeffects
AT elmorsyahmed designsynthesisandcytotoxicevaluationofnovelchalconederivativesbearingtriazolo43aquinoxalinemoietiesaspotentanticanceragentswithdualegfrkinaseandtubulinpolymerizationinhibitoryeffects
AT ihmaidsaleh designsynthesisandcytotoxicevaluationofnovelchalconederivativesbearingtriazolo43aquinoxalinemoietiesaspotentanticanceragentswithdualegfrkinaseandtubulinpolymerizationinhibitoryeffects
AT ahmedhanyea designsynthesisandcytotoxicevaluationofnovelchalconederivativesbearingtriazolo43aquinoxalinemoietiesaspotentanticanceragentswithdualegfrkinaseandtubulinpolymerizationinhibitoryeffects